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Abstract
The combined activation of the cellular energy sensor AMP-activated pro-
tein kinase (AMPK) and the nuclear transcription factor peroxisome prolif-
erator-activated receptor delta (PPARd) has been demonstrated to improve
endurance and muscle function by mimicking the effects of exercise train-
ing. However, their combined pharmacological activation with exercise
training has not been explored. Balb/c mice were trained on a treadmill
and administered both the AMPK activator AICAR and the PPARd agonist
GW0742 for 4 weeks. AICAR treatment potentiated endurance, but the
combination of AICAR and GW0742 further potentiated endurance and
increased all running parameters significantly relative to exercised and
nonexercised groups (138–179% and 355% increase in running time,
respectively). Despite the lack of change in basal whole-body metabolism, a
significant shift to fat as the main energy source with a decline in carbohy-
drate utilization was observed upon indirect calorimetry analysis at the per-
iod near exhaustion. Increased energy substrates before exercise, and
elevated muscle nonesterified fatty acids (NEFA) and elevated muscle glyco-
gen at exhaustion were observed together with increased PDK4 mRNA
expression. Citrate synthase activity was elevated in AICAR-treated groups,
while PGC-1a protein level tended to be increased in GW0742-treated
groups. At exhaustion, Pgc1a was robustly upregulated together with Pdk4,
Cd36, and Lpl in the muscle. A robust upregulation of Pgc1a and a down-
regulation in Chrebp were observed in the liver. Our data show that com-
bined pharmacological activation of AMPK and PPARd potentiates
endurance in trained mice by transcriptional changes in muscle and liver,
increased available energy substrates, delayed hypoglycemia through glyco-
gen sparing accompanied by increased NEFA availability, and improved
substrate shift from carbohydrate to fat.
Introduction
AMPK is a cellular energy sensor activated during condi-
tions of stress via upstream kinases. It is sensitive to the
ratio of AMP to ATP during periods of energy depriva-
tion such as in exercise, hypoxia, and starvation (Shack-
elford and Shaw, 2009). Reactive oxygen species produced
in the mitochondria during hypoxia and influx of calcium
during muscle contraction or nerve stimulation in other
organs also activate AMPK (Hawley et al. 2005; Jensen
et al. 2007; Mungai et al. 2011). The phosphorylation of
AMPK at its a subunit leads to a cascade of events
involving direct immediate control of metabolism by
promoting energy production while inhibiting energy
expensive anabolic processes (Winder and Hardie 1996;
Kurth-Kraczek et al. 1999; Horman et al. 2002). It also
functions indirectly in energy homeostasis by regulating
gene expression through activation or repression of tran-
scription (J€ager et al. 2007; Yang et al. 2009; Chen et al.
2010; Li et al. 2011). Its beneficial role has been widely
recognized because of its central role in metabolism par-
ticularly in improving fat oxidation and glucose uptake in
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the muscle, and improvement of lipid handling and oxi-
dation in both fat depots and liver, thereby ameliorating
metabolic disorders.
PPARs are nuclear transcription factors which function
as lipid sensors leading to transcriptional programming
within cells. The PPAR isotypes are present in most tis-
sues but vary in abundance and function as defined by
their target genes. PPARc is abundantly expressed in the
adipose tissues orchestrating adipogenic differentiation,
lipogenesis, and insulin sensitivity (Desvergne and Wahli
1999; Ahmadian et al. 2013). PPARa is highly expressed
in the liver and other oxidative tissues such as the heart
and skeletal muscle where it regulates oxidative metabo-
lism of fat (Desvergne and Wahli 1999; Lefebvre et al.
2006). PPARd, highly abundant in the skeletal muscle
and present in other metabolic organs albeit in moderate
expression, has been shown to regulate the change to an
oxidative phenotype characterized by increased fatty acid
oxidation, preferential use of fatty acids as substrate, but
with improved glucose uptake (Kr€amer et al. 2007; Reilly
and Lee 2008). The potential of PPARd in the manage-
ment of metabolic disorders has been recognized by
many researchers owing to its positive role in both fat
and glucose utilization. Moreover, its role in the
improvement of exercise performance has been demon-
strated both by genetic manipulation and by pharmaco-
logical activation (Wang et al. 2004; Narkar et al. 2008;
Gan et al. 2011).
The interaction of AMPK and PPARd has been investi-
gated in different contexts. For example, despite the lack
of exercise training, mice that underwent 4 weeks of
treatment with AICAR together with PPARd selective ago-
nist GW501516 had increased expression of genes related
to endurance training thus termed “exercise mimetics”
(Narkar et al. 2008). In another study, the mouse model
of muscle dystrophy Mdx mouse showed improved mus-
cle functional performance with exercise and the above-
mentioned drugs in some tests albeit not improving in
the running test (Bueno Junior et al. 2012). It has been
demonstrated that AMPK and PPARd, but not PPARa,
physically interact leading to an increase in glucose oxida-
tion via the upregulation of the lactate dehydrogenase B
(LDHB) gene associated with improved exercise perfor-
mance (Narkar et al. 2008; Gan et al. 2011). Much work
is still needed to reveal the complexity of AMPK and
PPARd interaction as well as interaction with other PPAR
isotypes.
The combined pharmacological activation of AMPK
and PPARd raised a question whether their activators
could further improve endurance above that brought
about by an exercise training regimen in healthy individu-
als. In connection to this, considering the consistent
demand for ergogenic aids and recovery supplements
(Maughan 1999), the use of these chemicals as doping
substances being reported was not surprising despite
insufficient safety and efficacy studies in humans. To be
able to identify food components and natural compounds
with similar benefits, we initially determined the effects of
combined AMPK and PPARd activation in trained mice.
We show that considerable improvements in endurance
could be attained with combined pharmacological activa-
tion in healthy exercise-trained mice.
Materials and Methods
Animals and drugs
Male 7-week-old Balb/c mice (Shimizu Laboratory Sup-
plies Co. Ltd., Kyoto, Japan) were utilized in the study.
The animals were divided into five groups and acclima-
tized to the housing environment 7 days before the exper-
imental treatments while receiving daily handling and i.p.
injection of saline (5 mL kg BW1) to eliminate the effect
of stress at the start of the treatments. All animals were
housed in a room maintained at 22  0.5°C, 50%
humidity, and a light–dark cycle of 12 h (6:00 lights on;
18:00 lights off). Mice had free access to standard diet for
mature rodents (D10012m, AIN-93M; Research Diets,
New Brunswick, NJ) and water. Mice in one group
received the vehicle DMSO (Wako Pure Chemicals,
Osaka, Japan) at 2.5% concentration in physiological sal-
ine and were not exercise-trained (hereby termed SED).
The other four groups received treatment together with
exercise training. The vehicle group (hereby termed V)
received the vehicle. The PPARd group (hereby termed
G) received the potent and selective agonist GW0742
(5 mg kg BW1, s.c.; Sta. Cruz Biotechnology, Santa
Cruz, CA). The AMPK group (hereby termed A) received
the activator AICAR (500 mg kg BW1, i.p.; Wako Pure
Chemicals), and the combined pharmacological activation
group (hereby termed A+G) received both GW0742 and
AICAR at the same dosage as groups G and A. The
administered dose of AICAR was similar to Narkar et al.
(2008). GW0742 dosage used was similar to the dosage of
another PPARd selective and potent agonist GW501516
used in the same paper. All administered solutions were
prepared to provide a target dosage in a volume of
5 mL kg BW1. Injections and/or exercise training were
conducted daily between 8:00 and 12:00 for 4 weeks. Mice
assigned to sedentary indirect calorimetry were placed in
metabolic chambers from day 26 to acclimatize as
described in the succeeding section. Mice assigned to
exercise-to-exhaustion test with indirect calorimetry were
left undisturbed for 3 days. Animal experiments were in
accordance to the Kyoto University Guidelines for the
Ethical Treatment of Laboratory Animals.
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Exercise training protocol
The experiment schedule is depicted in Figure 1A. In brief,
mice in the exercise-trained groups (V, G, A and A+G)
were accustomed to a rodent treadmill (MK-680; Muro-
machi, Tokyo, Japan) by walking for 15 min on 2 alternate
days before commencing with the actual training program.
Training was conducted on alternate days for 4 weeks with
the last two training sets done on a rodent treadmill
enclosed in a metabolic chamber (Columbus Instruments,
Columbus, OH) coupled to a mass spectrometer (ARCO-
2000; Arco System, Tokyo, Japan). A weekly increasing
intensity protocol was followed (Fig. 1B). Briefly, warm-up
was conducted at the following program: 6 m min1 for
1 min, 8 m min1 for 2 min followed by 10 m min1 for
2 min. Following warm-up, the intensity was set to
12 m min1 for 20 min. On the second week, the warm-
up program included 12 m min1 for 2 min and followed
by the intensity of 15 m min1 for 20 min. On the third
week, the warm-up program included 15 m min1 for
2 min and followed by the intensity of 18 m min1 for
25 min. Finally, on the fourth week, the warm-up program
included 18 m min1 for 2 min and followed by the inten-
sity of 21 m min1 for 25 min. An electric stimulus of
0.5 V was employed to force the mice to run. All mice in
the exercise-trained groups were able to fully comply with
the training protocol. Mice in the SED group were acclima-
tized on the rodent treadmill only on the last two training
days (Fig. 1A).
Sedentary indirect calorimetry
Mice were placed in metabolic chambers on day 26 to
acclimatize as well as eliminate the effect of environmen-
tal stress (Fig. 1A). After the final exercise training bout
and drug treatment, sedentary indirect calorimetry were
conducted on mice designated to the before-exercise
group. In brief, mice were kept in metabolic chambers
and indirect calorimetry was conducted on day 29 for
48 h. Respiratory gases (O2 and CO2) from each chamber
were measured and respiratory quotient (RQ), oxygen
consumption, carbohydrate oxidation, and fat oxidation
were calculated relative to the body weight of mice. The
room was maintained at 25  2°C at a relative humidity
of 40–90%. The same diet and water were supplied ad libi-
tum during measurement. The apparatus had 16 lanes
each connected to a metabolic chamber (internal dimen-
sion: 10 9 16 9 8 cm). Mass spectrometer (ARCO-2000;
Arco System), and air-lane switching system sampler
(ARCO-2000-GS-16; Arco System) were used to measure
oxygen consumption and RQ. An activity meter on top
of each chamber counted movement. Fat oxidation and
carbohydrate oxidation was automatically calculated from
the amount of oxygen consumed and respiratory gas
exchange ratio using the ARCO-2000 software coupled to
the equipment according to the formula by Frayn (1983),
while energy expenditure was calculated using the formula
by Lusk (1924). Data during the last 24 h were analyzed
and presented.
Figure 1. Schedule and exercise protocols. (A) Experiment schedule, (B) training protocol on the treadmill, (C) exercise-to-exhaustion test with
indirect calorimetry protocol.
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Two hours prior to sacrifice, food was removed from
each chamber. Mice were sacrificed by decapitation and
blood was collected. Blood was centrifuged and the
collected serum was stored at 80°C for subsequent
analyses. Gastrocnemius and a piece of the liver were
clamp-frozen in liquid nitrogen and stored at 80°C for
metabolite quantification. Data from these samples were
referred in-text as before exercise or pre-exercise test data.
Weights of right gastrocnemius, right epididymal fat, and
whole liver were recorded.
Exercise-to-exhaustion test with indirect
calorimetry
Three days after the final exercise training bout and drug
treatment, exercise-to-exhaustion test was conducted
(Fig. 1C). In brief, mice were weighed and placed in an air-
tight indirect calorimetry treadmill chamber undisturbed
for 1.5 h. The treadmill was set at an inclination of 3° and
running was commenced at an initial intensity of
6 m min1 gradually increasing by 1 m min1 every
30 sec until the intensity of 12 m min1 was reached total-
ing to 3 min. This intensity was maintained for 27 min.
The inclination was increased to 20° followed by increasing
the intensity by 2 m min1 every min until the intensity of
24 m min1 was reached. An electric stimulus of 0.5 V was
employed to force the mice to run. This was kept constant
until the mice were deemed unable to continue running.
Exhaustion was defined as remaining on the shocker plate
for 10 sec in spite of momentary increases in electrical
stimulus together with tapping on the chamber walls as an
auditory stimulus. Indirect calorimetry was conducted
before and during exercise using the same system in the
sedentary-state indirect calorimetry section.
At the point of exhaustion, mice were immediately sac-
rificed and samples were collected similar to mice in the
sedentary state. In addition, quadriceps and a piece of the
liver were stored in RNAlater RNA Stabilization Reagent
(Qiagen, Hilden, Germany) according to the manufac-
turer’s instructions until total RNA extraction. Data from
these samples were referred in-text as after exhaustion or
postexercise test data.
Serum glucose, triglycerides, and
nonesterified fatty acids
Serum glucose concentration was measured using an
enzymatic colorimetric test kit (Glucose C I Test Wako;
Wako Pure Chemicals Industries, Osaka, Japan) on a 96-
multiwell plate reader. Serum triglycerides (TG) and non-
esterified fatty acids (NEFA) were measured using the
Triglyceride E and NEFA C Test Kits, respectively (Wako
Pure Chemicals Industries).
Muscle and liver glycogen
Frozen gastrocnemii and liver samples were powdered in
liquid nitrogen-submerged mortar and pestle. Glycogen
was extracted using the following method in our labora-
tory. In brief, weighed samples approximately 100 mg
was digested in 0.3 mL of 30% KOH solution in a heat-
ing block set at 100°C for 30 min. The resulting digest
was cooled on ice followed by the addition of 50 lL satu-
rated Na2SO4 and 0.5 mL ice-cold ethanol. The mixture
was vortexed and spun down at 2300 g for 5 min. The
glycogen precipitate was dissolved in 200 lL distilled
water followed by 250 lL ice-cold ethanol precipitation.
The mixture was centrifuged to pellet the glycogen and
the supernatant discarded. To convert the glycogen to
glucose units, 0.6 mL of 0.6 mol L1 HCl was added and
heated on a heating block set at 100°C for 2 h. Measure-
ment of glucose was similar to that of serum glucose.
Glucose was converted to glycogen by factoring the water
eliminated if glucose units were polymerized.
Muscle and liver nonesterified fatty acids
From the powdered tissue samples, approximately 50 mg
were weighed. One mL of Folch reagent (chloroform:
methanol, 2:1) was added to the sample and then vor-
texed. The mixture was incubated at 4°C for 16 h. To
obtain the lipid containing fraction, 0.2 mL of
4 mmol L1 MgCl2 was added then vortexed. The mixture
was centrifuged at 1200 g for 1 h at 4°C. From the lower
chloroform layer containing the extracted lipids, 0.2 mL
was collected and the solvent evaporated. The desolvated
lipids were resuspended in 0.1 mL 10% triton-X in iso-
propanol. NEFA was measured using the NEFA C Test kit.
Reverse transcriptase quantitative
polymerase chain reaction (RT-qPCR)
Pre-exercise clamp-frozen gastrocnemius samples and
postexercise quadriceps and liver stored in RNAlater were
powdered in liquid nitrogen. Total RNA was extracted
using a combination of TriPure Isolation Reagent (Roche,
Mannheim, Germany) and RNeasy Mini Kit (Qiagen). In
brief, approximately 100 mg of the sample was mixed
with 1 mL TriPure reagent followed by brief sonication.
The mixture was clarified by centrifugation and 0.2 mL
chloroform was added to the supernatant. The mixture
was vortexed followed by centrifugation at 12,000 g for
15 min at 4°C. Equal parts of 70% ethanol and super-
natant were combined, mixed, and then transferred to an
RNeasy spin column. The succeeding steps were accord-
ing to the manufacturer’s instructions with DNase I
(Qiagen) digestion. Total RNA was reverse transcribed
2016 | Vol. 4 | Iss. 5 | e12625
Page 4
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
AMPK With PPARd Potentiates Endurance in Trained Mice M. C. C. Manio et al.
with M-MLV reverse transcriptase (Promega, Madison,
WI) and RNase Inhibitor (Toyobo, Osaka, Japan). Mes-
senger RNA expression levels were measured from signals
from Universal ProbeLibrary probes (Roche).
Intron spanning oligonucleotide primer sets of mouse
genes were designed using the program at the website of
Roche Universal ProbeLibrary Assay Design Center and
the predicted amplicons were validated using the program
at the BLAST website of the National Institutes of Health.
Primer sequences are as follows: hypoxanthine–guanine
phosphoribosyltransferase (HPRT) as an internal control
(Fwd: 50-TCCTCCTCAGACCGCTTTT-30; Rev: 50-CCTGG
TTCATCATCGCTAATC-30), peroxisome proliferator-acti-
vated receptor 1-alpha transcript variant 1 (PCG1a/PPAR
GC1a) (Fwd: 50-TGTGGAACTCTCTGGAACTGC-30; Rev:
50-AGGGTTATCTTGGTTGGCTTTA-30), pyruvate dehy-
drogenase kinase 4 (PDK4) (Fwd: 50-CGCTTAGTGAACAC
TCCTTCG-30; Rev: 50-CTTCTGGGCTCTTCTCATGG-30),
lipoprotein lipase (LPL) (Fwd: 50-GCTCATGATGAAGCT
TAAGTGGA-30; Rev: 50-TCCCTAGCACAGAAGATGACC
-30), fatty acid translocase (FAT/CD36) (Fwd: 50-TTGTAC
CTATACTGTGGCTAAATGAGA -30; Rev: 50-CTTGTGTT
TTGAACATTTCTGCTT-30), muscle carnitine palmitoyl-
transferase 1 (CPT1b) (Fwd: 50-GCCCATGTGCTCCT
ACCA-30; Rev: 50-CTCTGAGAGGTGCTGTAGCAAG-30),
uncoupling protein 3 (UCP3) (Fwd: 50-TGCTGGAGTCT
CACCTGTTTAC-30; Rev: 50-CGGGTCTTTACCACATC
CAC-30), vascular endothelial growth factor A (VEGFa)
(Fwd: 50-ACTGGACCCTGGCTTTACTG-30; Rev: 50-TCTG
CTCTCCTTCTGTCGTG-30), hormone sensitive lipase
(LIPE/HSL) (Fwd: 50-AGCGCTGGAGGAGTGTTTT-30;
Rev: 50-CCGCTCTCCAGTTGAACC-30), citrate synthase
(CS) (Fwd: 50-CTGCCTGAGGGCTTATTTTG-30; Rev: 50-
CATTCTCGTGAGAGCCAAGAC-30), PPARd (PPARD)
(Fwd: 50-GAAGTGGCCATGGGTGAC-30; Rev: 50-GAGGA
AGGGGAGGAATTCTG-30), glucose transporter type 4
(GLUT4) (Fwd: 50-GACGGACACTCCATCTGTTG-30;
Rev: 50-GCCACGATGGAGACATAGC-30), adipose triglyc-
eride lipase (ATGL) (Fwd: 50-CGGGTA GCATCTGC-
CAGTA-30; Rev: 50-CAGTTCCACCTGCTCAGACA-30), 3-
oxoacid CoA-transferase (OXCT1) (Fwd: 50-AGGCCTGAC
TGTTGATGACA-30; Rev: 50-CTGCATTGGCATGAGG
TTT-30), muscle glycogen phosphorylase (PGYM) (Fwd:
50-AGTGGAGGACGTGGAAAGG-30; Rev: 50-GCTCAGGA
ATTCGGTCGTAG-30), muscle glycogen synthase (GSY1)
(Fwd: 50-GGGGTCTTCCCCTCCTACTA-30; Rev: 50-CTCC
ATAAAGCAGCCAAAGC-30), and carbohydrate-respon-
sive element-binding protein (CHREBP) (Fwd: 50-CTTCA
GCAGTGGGATCCTG-30; Rev: 50-ATCCAAGGGTCCAGA
GCA-30). Messenger RNA expression results were normal-
ized to Hprt expression and presented as a ratio relative to
SED. HPRT was used as the reference gene because it is
stable in the context of exercise (Cappelli et al. 2008).
Mitochondrial DNA copy number
Total DNA was isolated from powdered gastrocnemius
samples using the QIAamp DNA Mini Kit (Qiagen).
Independent reactions were performed for mitochondrial
DNA cytochrome c oxidase subunit I (COI) and nuclear
18S rDNA using the primers as detailed by Tal et al.
(2009) with the LightCycler Carousel-Based System
(Roche). Primers used to amplify mouse DNA are as fol-
lows: 18S rDNA forward, 50-TAGAGGGACAAGTGGCG
TTC-30; 18S rDNA reverse, 50-CGCTGAAGCCAGTCA
GTGT-30; COI forward, 50-GCCCCAGTATAGCATTCCC-
30; and COI reverse, 50-GTTCATCCTGTTCCTGCTCC-30.
In brief, 5 ng of total DNA was used with the SYBR green
I reaction system (Roche) according to the manufacturer’s
instructions. Temperature cycling program as detailed by
Brown and Clayton (2002) with some modifications
are as follows: initial denaturation at 95°C for 30 sec fol-
lowed by 40 cycles at 95°C for 3 sec, 55°C for 6 sec then
72°C for 10 sec each cycle with ramping rate set at
20°C sec1. Data were acquired at the end of the
extensions at 72°C. At the end of the program, the homo-
geneity of the amplicons was confirmed by a melting
curve analysis. Relative copy number are expressed as the
ratio of mtDNA COI over 18S rDNA then rationalized to
SED.
Immunoblotting
Approximately 10 mg gastrocnemius samples were
homogenized in 500 lL cold RIPA lysis buffer with
EDTA supplemented with protease and phosphatase inhi-
bitor cocktail tablets (Roche). Insoluble matter was pre-
cipitated by centrifugation at 10,000 g, 4°C for 20 min
and the lysate collected and protein content measured
using the Coomassie Brilliant Blue solution (Nacalai Tes-
que, Kyoto, Japan). Lysate was adjusted with lysis buffer
to achieve similar concentrations among samples followed
by addition of 49 Laemmili buffer containing b-mercap-
toethanol. Samples (33 lg protein) were subjected to elec-
trophoresis followed by transfer to a nitrocellulose
membrane. Membranes were incubated in Ponceau S
stain then rinsed with excess water to remove unbound
stain. These were then sandwiched in glass plates then
photographed and digitized (LAS-3000, Fujifilm, Tokyo,
Japan). After digitization, membranes were washed in
TBS-T buffer to remove bound stain then followed by
blocking in 2% BSA in TBS-T. Membranes were cut at
previously identified locations to separate PGC-1a and a-
Tubulin containing regions. Respective primary antibody
incubation was done with anti-a-Tubulin antibody and
anti-PGC-1a antibody (Santa Cruz Biotechnology) over-
night. Membranes were sufficiently washed and incubated
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with respective secondary antibodies linked to horseradish
peroxidase (Dako, Glostrup, Denmark). Immunodetection
by chemiluminescence (Western Lightning Plus ECL, Per-
kinElmer, Waltham, MA) was conducted according to the
manufacturer’s directions followed by visualization using
the LAS-3000 equipment. Quantification of total signals
from Ponceau S, and protein-specific chemiluminescent
signals were performed using the coupled software (Mul-
tiGauge V.3.2, Fujifilm, Tokyo, Japan). Relative protein
expression was obtained by comparing protein-specific
signals to total Ponceau S signal.
Citrate synthase activity
Muscle lysates were diluted with the lysis buffer to achieve
a similar protein concentration of 2 lg lL1. The princi-
ple of the assay is based on the paper by Srere (1969). In
a 96-well plate, 4 lL of adjusted lysate (8 lg protein) was
mixed with acetyl-CoA (Roche, Indianapolis, IN) dis-
solved in 0.1 mol L1 Tris-HCl buffer at pH 8.0 and
DTNB (Sigma-Aldrich, Hamburg, Germany) dissolved in
ethanol. After thorough mixing, deacetylase activity was
measured at 412 nm on a kinetic program of a 96-well
plate reader for 2.5 min with 50-sec interval between each
reading. Citrate synthase reaction was initiated by the
addition of oxaloacetate (Sigma-Aldrich) dissolved in the
same buffer. Final concentrations of reactants were as fol-
lows: 0.3 mmol L1 acetyl-CoA, 0.1 mmol L1 DTNB,
and 0.1 mmol L1 oxaloacetate. The plate was immedi-
ately shaken and absorbance at 412 nm was read on a
kinetic program with the duration of 10 min and an
interval of 50 sec between each reading. Beyond this time,
absorbance readings deviated from linearity. The change
in absorbance before the addition of oxaloacetate was
subtracted from the change in absorbance after the addi-
tion of oxaloacetate. Citrate synthase activity is expressed
relative to protein loaded.
Statistical analysis
Statistical analysis was performed using Prism 5.0 (Graph-
pad Software, La Jolla, CA). Time course data values of
indirect calorimetry are presented as means. Average and
cumulative values in different experiments are presented
as mean  SEM. One-way analysis of variance (ANOVA)
followed by Newman–Keuls post hoc test was applied to
determine the presence of significant differences among
groups. Student’s t-test was applied to within-group pre-
and postexercise data. Significance level was set at
a = 0.05 and P values lower than a were considered sig-
nificant.
Results
Body weight and sedentary-state indirect
calorimetry
The effects of combined pharmacological activation on
body weight, organ weight, RQ, oxygen consumption, car-
bohydrate and fat oxidation, energy expenditure, and spon-
taneous motor activity were measured. No significant effect
on body weight, gastrocnemius, and epididymal fat weights
were observed (Table 1). However, liver weight was signifi-
cantly increased in G (P < 0.05) relative to SED, and in
A+G (P < 0.001) relative to all groups. No significant dif-
ferences were observed in RQ, total oxygen consumption,
carbohydrate and fat oxidation, energy expenditure, and
spontaneous motor activity among groups (Fig. 2A–F).
Running endurance
To determine the effect of the activators on endurance in
trained mice, mice were subjected to an exercise-to-
exhaustion test. As expected, mice in the SED group were
not able to run at the same time as the exercise-trained
groups (Fig. 3A and B). All the trained groups were able
to run more than twice (P < 0.001) the time to exhaus-
tion of SED. Among them, only A+G was able to run
longer (P < 0.001) than V. A tendency for Group A to
run longer was observed. The total distance covered until
exhaustion was also calculated from the running time
(Fig. 3C). However, work may be a more appropriate
measure as it takes into account body weight. Indeed, cal-
culating for work showed that A did significantly more
(P < 0.05) than both V and G however, A+G was still sig-
nificantly higher (P < 0.001) even to A (Fig. 3D). These
Table 1. Body and organ weights.
SED V G A A+G
Body weight (g) 24.73  0.360 25.36  0.527 24.10  0.471 24.80  0.276 25.70  0.435
Gastrocnemius (% of total BW) 0.5227  0.014 0.5469  0.013 0.5507  0.013 0.5613  0.014 0.5594  0.006
Liver (% of total BW) 4.314  0.07054a 4.554  0.1232a 4.917  0.1648b 4.530  0.09468a 5.463  0.08814c
Epididymal fat (% of total BW) 0.7654  0.572 0.7063  0.042 0.7054  0.054 0.7886  0.062 0.7541  0.049
Different superscript notations indicate significant difference (P < 0.05–0.001).
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results show that AICAR could potentiate endurance in
trained mice. Furthermore, the combination of AICAR
and GW0742 in A+G could further potentiate endurance
than that imparted solely by AICAR.
Exercise-to-exhaustion indirect calorimetry
The effects of combined pharmacological activation on
whole-body metabolism were examined by indirect
calorimetry before and during the running test. Only values
obtained during the first 45 min of the run wherein SED
was capable of completing were calculated to facilitate sta-
tistical comparison of all groups. No considerable differ-
ences were observed at each time point in the time course
curves (Fig. 4A–E; curve) similar to the observation in
sedentary-state indirect calorimetry. Calculating for the
average RQ, and total oxygen consumption and carbohy-
drate and fat oxidation before running, no significant dif-
ferences were observed among the groups regardless of
training status (Fig. 4A–E; rest bar). However, during the
run, the exercise-trained groups had significantly lower
(P < 0.05) average RQ compared to SED (Fig. 4A; run
bar). Total oxygen consumption, fat oxidation, and energy
expenditure did not show any significant differences
(Fig. 4B, D and E; run bar). Only A had significantly
decreased carbohydrate oxidation (P < 0.05) relative to
SED although G and A+G had a tendency to have lower
total carbohydrate oxidation (Fig. 4C; run bar).
To visualize the changes in substrate oxidation before
reaching exhaustion, the same calculation as above was
applied to the last 10 time points corresponding to the
last 30 min before exhaustion of each mice (Fig. 4F–J;
Figure 2. Combined pharmacological AMPK and PPARd activation does not influence basal metabolism. Indirect calorimetry with activity
measurement was conducted in the sedentary state. (A) Respiratory quotient (RQ), (B) oxygen consumption, (C) carbohydrate oxidation, (D) fat
oxidation, (E) energy expenditure, and (F) spontaneous motor activity. The graph on the left depicts values at each time point while that on the
right shows the average (only for RQ) or cumulative values within 24 h. Data are expressed as means  SEM (n = 8–9). No significant
differences were observed as analyzed by one-way ANOVA.
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curve). The average RQ was further decreased in all exer-
cise-trained groups with the highest decrease in A+G
(Fig. 4F, bar). Total oxygen consumption was not differ-
ent among groups (Fig. 4G; bar). Interestingly, total car-
bohydrate oxidation of all exercise-trained groups showed
a decrease (P < 0.01–0.001) >50% that of SED (Fig. 4H;
bar). Also, A+G had a further drop about 50% that of V,
G, or A. Fat oxidation, on the other hand, was elevated
(P < 0.05) in A+G relative to SED in contrast to the lack
of difference during the 45 min run (Fig. 4I; bar). This
suggests an enhanced shift in fuel source during pro-
longed exercise especially near exhaustion as energy
expenditure among all groups was not significantly differ-
ent (Fig. 4J; bar).
Serum glucose
Serum glucose before exercise and after exhaustion was
measured because hypoglycemia during exercise is impli-
cated as one of the factors that lead to exercise cessation
(Williams et al. 2013). Serum glucose before exercise was
significantly increased in A+G relative to all the other
groups. At the point of exhaustion, serum glucose was
decreased (P < 0.01–0.001) at about similar levels in all
exercise-trained groups irrespective of treatment com-
pared to SED (Fig. 5A). And this decrease was significant
(P < 0.001) relative to the before-exercise glucose levels.
The SED group on the other hand did not have a signifi-
cant decrease even at the point exhaustion.
Serum TG and NEFA
Serum TG and NEFA are sources of fatty acids as energy
source during exercise. Serum TG before exercise was
similar among groups with A+G having a nonsignificant
increase (Fig. 5B). No intergroup differences were
observed at the point of exhaustion. Comparison of pre
and postexercise values showed a significant decrease
(P < 0.05–0.01) in all groups except V.
Pre-exercise serum NEFA was similar among the
groups (Fig. 5C). At the point of exhaustion, serum
NEFA significantly increased (P < 0.001) relative to
before exercise despite an apparent lower concentration
in G. This low concentration was only significantly differ-
ent (P < 0.05) with A+G.
Muscle and liver glycogen
Both muscle and hepatic glycogen were measured because
glycogen plays a role in the maintenance of glucose
homeostasis in the blood (Baldwin et al. 1973). Before
exercise, the basal level of muscle glycogen was signifi-
cantly elevated (P < 0.05–0.01) in A+G relative to all
groups. At the point of exhaustion, muscle glycogen in A
and A+G remained elevated (P < 0.01–0.001) compared
to the other groups (Fig. 5D). Furthermore, A+G was sig-
nificantly higher (P < 0.05) than A. Comparison of pre
and postexercise muscle glycogen showed that all groups
had decreased. However, the decrease in A and A+G was
Figure 3. Combined pharmacological AMPK and PPARd activation improves endurance in trained mice. Mice were subjected to exercise-to-
exhaustion test. (A) Percentage of running population on the treadmill, (B) total running time to exhaustion, (C) total distance covered, and
(D) total work done. Data are expressed as means  SEM (n = 7–8). Significant differences were analyzed by one-way ANOVA followed by
Newman-Keuls multiple comparison test. Asterisk (*), plus sign (+), slash (/) and dagger (†) represent significant difference relative to SED, V,
G and A, respectively. Single symbols indicate P < 0.05 while triple symbols indicate P < 0.001.
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Figure 4. Combined pharmacological AMPK and PPARd activation promotes enhanced substrate shift during prolonged exercise in trained
mice. Indirect calorimetry was conducted before and during the exercise-to-exhaustion test. (A) Respiratory quotient (RQ), (B) oxygen
consumption, (C) carbohydrate oxidation, (D) fat oxidation, and (E) energy expenditure. The same parameters were measured during the last
30 min until exhaustion: (F) RQ, (G) oxygen consumption, (H) carbohydrate oxidation, (I) fat oxidation, and (J) energy expenditure. Time course
data are expressed as means while average RQ and cumulative values are expressed as means  SEM (n = 6). Significant differences were
analyzed by one-way ANOVA followed by Newman-Keuls multiple comparison test. *P < 0.05; **P < 0.01; and ***P < 0.001 relative to SED.
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not statistically significant compared with the other
groups (P < 0.001).
In the liver, pre-exercise hepatic glycogen had a tendency
to be lower in exercise-trained groups (Fig. 5E). Because of
increased liver weight in G and A+G (Table 1), calculating
for absolute liver glycogen showed that SED and A+G had
almost similar total glycogen while the other groups had





Figure 5. Combined pharmacological AMPK and PPARd activation increases available substrates and muscle glycogen sparing in trained mice.
Blood, gastrocnemius and liver were collected at rest and at the point of exhaustion. (A) Serum glucose, (B) serum TG, (C) serum NEFA, (D) muscle
glycogen, (E) liver glycogen, (F) total liver glycogen, (G) muscle NEFA and (H) liver NEFA were measured. Data are expressed as means  SEM
(n = 8–9, at rest; 7–8, at exhaustion). Inter-group significant differences were analyzed by one-way ANOVA followed by Newman-Keuls multiple
comparison test while intra-group differences were analyzed by unpaired Student’s t-test. Asterisk (*), plus sign (+), slash (/) and dagger (†) represent
significant difference relative to SED, V, G and A, respectively. Single symbols, P < 0.05; double symbols, P < 0.05 while triple symbols, P < 0.001.
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exercise-trained groups had similar depleted glycogen
stores about 159 less (P < 0.001) than SED (Fig. 5E). All
groups had decreased glycogen postexercise (P < 0.001),
but the decrease in SED did not drop to the same extent as
in the exercise-trained group.
Muscle and liver NEFA
Because NEFA, albeit measured in plasma, delay the
depletion of glycogen during exercise (Rennie et al.
1976), NEFA within the tissues were measured as no
Figure 6. Combined pharmacological AMPK and PPARd activation influences gene expression of substrate utilization related genes in skeletal
muscle in trained mice. Pre-exercise test (A) Pgc1a, Pdk4 and Lpl expression and, (B) representative immunoblot image of PGC-1a and a-
Tubulin, and Ponceau S digitized image, and (C) relative PGC-1a protein expression in gastrocnemius muscle. Post-exercise test messenger RNA
expression of (D) PGC-1a and genes related to (E) fatty acid availability, (F) glucose availability, (G) mitochondrial oxidative metabolism, and (H)
Ppard and Vegfa were measured. For mRNA expression, data were normalized to Hprt expression while for protein expression, data were
normalized to total Ponceau S signal. Data were rationalized to SED, and expressed as means  SEM (pre-exercise test n = 6, postexercise test
n = 7–9). Significant differences were analyzed by one-way ANOVA followed by Newman-Keuls multiple comparison test. Asterisk (*), plus sign
(+), slash (/) and dagger (†) represent significant difference relative to SED, V, G and A, respectively. Single symbols, P < 0.05; double symbols,
P < 0.01; while triple symbols, P < 0.001.
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2016 | Vol. 4 | Iss. 5 | e12625
Page 11
M. C. C. Manio et al. AMPK With PPARd Potentiates Endurance in Trained Mice
significant differences were observed in serum NEFA at
least relative to SED at the point of exhaustion. Pre-
exercise muscle NEFA were similar in all groups except
in V where a significant decrease (P < 0.05–0.01)
relative to SED, A and A+G was observed (Fig. 5G).
However, at the point of exhaustion, muscle NEFA was
increased (P < 0.01) in A+G relative to SED. Moreover,
A+G had 25% more NEFA in the gastrocnemius than
other exercise-trained groups. Muscle NEFA decreased
after exercise however, in V where pre-exercise NEFA
was lower, the observed decrease was not statistically
significant.
Liver NEFA, on the other hand, is the source of circu-
lating NEFA and ketone bodies. Pre-exercise values were
similar among groups, however, at exhaustion, exercise-
trained groups significantly increased (P < 0.001) relative
to SED (Fig. 5H). An increase (P < 0.01–0.001) in all
groups relative to pre-exercise values were observed but
the level in SED was only about 50% that of the exercise-
trained groups.
Gene expression in the muscle
The transcriptional coactivator PGC-1a has been associ-
ated with phenotypic changes leading to improved exer-
cise. The effects of combined pharmacological activation
on the gene expression of this coactivator were deter-
mined. It should be noted that the primer used in the
study amplify the full-length, well-characterized transcript
variant 1. Before the exercise test in the gastrocnemius,
PGC-1a mRNA expression was not different among
groups regardless of training status (Fig. 6A). In A+G,
Pdk4 but not Lpl had significant upregulation (P < 0.05).
This elevation was not significant relative to A. Protein
expression, on the other hand, tended to remain elevated
after 72 h in the sedentary state in G and A+G, but not
in other exercise groups (Fig. 6B and C). Comparison
was made against total Ponceau S signal instead of com-
monly used loading controls. a-Tubulin expression
seemed to be influenced by exercise as its signal relative
to total Ponceau S stain tended to be lower in exercise-
trained groups relative to SED and was further lowered
by AICAR treatment (not shown). Likewise, b-actin
expression was variable despite similar amount protein
loaded among samples as quantified (not shown).
After the exercise test in the quadriceps, exercise train-
ing significantly increased (P < 0.05–0.001) PGC-1a
mRNA expression relative to SED (Fig. 6D). The lack of
significant differences among V, G, and A suggests that
individual drug administration does not increase Pgc1a
Figure 7. Combined pharmacological AMPK and PPARd activation
modifies hepatic mRNA expression of PGC-1a and CHREBP in
trained mice. After exhaustion, liver was analyzed for Pgc1a, and
Chrebp expression. Data were normalized to Hprt expression,
rationalized to SED, and expressed as means  SEM (n = 7–8).
Significant differences were analyzed by one-way ANOVA followed
by Newman-Keuls multiple comparison test. Asterisk (*), plus sign
(+), slash (/) and dagger (†) represent significant difference relative
to SED, V, G and A, respectively. Single symbols, P < 0.05 while
triple symbols, P < 0.001.
Figure 8. Pharmacological activation of AMPK but not PPARd improved skeletal muscle mitochondrial density in trained mice. (A) Relative
mtDNA copy number was measured by comparing the copy number of mitochondrial cytochrome oxidase I (COI) DNA with the copy number
of nuclear 18S rDNA. (B) Citrate synthase activity was measured from muscle lysates. Mitochondrial DNA copy number data were rationalized
to SED. Data are expressed as means  SEM (n = 8–9). Significant differences were analyzed by one-way ANOVA followed by Newman-Keuls
multiple comparison test. Asterisk (*), and slash (/) represent significant difference relative to SED, and G, respectively. Single symbols, P < 0.05
while double symbols, P < 0.01.
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expression above that of exercise training at least at the
time point measured. Interestingly, combined pharmaco-
logical activation in A+G further increased (P < 0.05) the
Pgc1a levels than V, G, and A. Expression of mRNA of
genes involved in fatty acid and glucose availability, mito-
chondrial genes, as well as PPARd and the angiogenic fac-
tor VEGFa were measured. Genes related to fatty acid
availability were all highly expressed in A+G (Fig. 6E). In
particular, AICAR treatment in A and A+G rescued the
decrease of Hsl and Atgl compared to V. Lpl increased
with AICAR treatment and A+G had the most robust
upregulation (P < 0.01). Cd36 was decreased in V, but
agonist treatment in G and A rescued it. Furthermore, it
was further increased in A+G relative to G and A
(P < 0.05). Glucose availability-related genes (Glut4, Gsy1,
and Pygm) did not change. However, a tendency to
increase with GW0742 treatment in Gsy1 and with either
agonist treatment in Pygm could be observed (Fig. 6F).
Messenger RNA expression of several mitochondrial
genes was also measured at exhaustion (Fig. 6G). Pdk4
was elevated by exercise and GW0742 in G induced a
significant increase (P < 0.05). The combination of
the activators in A+G significantly elevated Pdk4
(P < 0.05–0.001) relative to all groups and almost 150%
more than SED. Cpt1b was equally increased (P < 0.05)
in G and A+G, indicating no apparent significant effect of
AMPK activation. Cs was increased (P < 0.05–0.001) only
in the drug treated groups although a tendency for V to
increase could be observed. Oxct1 did not increase with
exercise or drug treatment. Ucp3 increased in G and A+G
but did not attain significance. The pattern of PGC-1a
protein expression in the exercise-trained groups in par-
ticular was clearly reflected in the above mentioned genes.
Exercise training increased the mRNA expression of
PPARd (Fig. 6H). However, only G had the highest
expression (P < 0.01) relative to SED. Messenger RNA
expression of VEGFA, another PGC-1a target, was
increased (P < 0.05–0.001) by exercise training with G
having the highest expression.
Gene expression in the liver
The maintenance of euglycemia during exercise is an
important function of the liver. Transcription-related
factors known to influence the synthesis and storage of
glucose in this organ were measured. At exhaustion,
Pgc1a increased in all drug-treated groups however, only
A+G was significantly different (P < 0.05) relative to
both SED and V (Fig. 7). The lipogenic transcription
factor CHREBP mRNA was significantly decreased
(P < 0.01–0.001) only in A+G. This was not observed
even in the other exercise-trained or drug-treated
groups. Both of these suggest increased synthesis and
storage of glycogen with repression of glycolytic and
lipogenic pathways in A+G (Burgess et al. 2006; Iizuka
and Horikawa 2008).
Mitochondrial density
PGC-1a is important in the stimulation of mitochondrial
biogenesis (Austin and St-Pierre 2012). Despite elevated
gastrocnemius PGC-1a protein expression in G and A+G
(Fig. 6B and C), mtDNA copy number was not increased
relative to SED (Fig. 8A). However, several studies
emphasized that citrate synthase may be a better marker
of mitochondrial biogenesis rather than mtDNA copy
number (Kim et al. 2008; Larsen et al. 2012). Indeed, a
tendency to have increased citrate synthase activity could
be observed in all exercise-trained groups (Fig. 8B). A
moderate but nonsignificant increase was observed in V
and G which was shadowed by the robust increase in
citrate synthase activity (P < 0.05–0.01) in AICAR-treated
groups.
Discussion
This study demonstrated that combined pharmacological
activation of AMPK and PPARd potentiates endurance in
exercise-trained mice. Although a small but significant
potentiation was observed with AMPK activation, in con-
trast to Narkar et al. (2008), no potentiation was
observed with PPARd activation. AMPK is a cellular sen-
sor of energy status, while PPARd is a transcription factor
known to induce a change toward an oxidative phenotype
in metabolic tissues (Barish et al. 2006; Liu et al. 2011;
Mihaylova and Shaw 2011). The lack of potentiation by
PPARd agonism in two independent trials in contrast
with Narkar et al. (2008) could be attributed to the dif-
ferences in agonists, mice strain, and training and exhaus-
tion test protocol. Despite this, our data are in agreement
with Bueno Junior et al. (2012) that combined activation
of AMPK and PPARd with exercise training elicits pheno-
typic changes related to physical performance probably
arise from the physical interaction of AMPK and PPARd
(Narkar et al. 2008; Gan et al. 2011).
Whole-body metabolism, both during sedentary and
early phase of exercise, were not different among groups.
However, in A+G, shift in fuel utilization from carbohy-
drate to fat was observed toward exhaustion without a
change in energy expenditure. Shift in whole-body fuel
utilization has been attributed to PDK4, a PGC-1a target
gene, and mitochondrial protein responsible for the pref-
erential b-oxidation of fatty acids with a decline in glycol-
ysis (Wende et al. 2005, 2007; Calvo et al. 2008). Indeed,
despite an absence of changes in PGC-1a mRNA tran-
scription and an increase, albeit not significant, protein
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expression in the gastrocnemius of A+G before the exer-
cise test, a small but significant elevation in Pdk4 could
observed. Furthermore, at exhaustion, Pdk4 expression
was increased significantly compared to all groups sup-
porting the shift in fuel utilization toward exhaustion in
A+G. In addition, PDK4 and PGC-1a mRNA expression
at exhaustion resembles that of fat oxidation toward
exhaustion.
Combined pharmacological activation of AMPK and
PPARd with exercise training increases substrate availabil-
ity. Serum glucose, muscle glycogen, and hepatic glycogen
were increased in A+G. With increased total available glu-
cose in the form of free glucose, skeletal muscle and hep-
atic glycogen, the onset of hypoglycemia during exercise
could be delayed. Increased basal glycogen in the muscle is
associated with increased preference to fatty acid oxidation
(Wong et al. 2014), while glycogen sparing during exercise
both in muscle and liver is influenced by increased NEFA
and substrate shift to fat by PDK4 thereby contributing to
improved endurance (Rennie et al. 1976; Hickson et al.
1977; Pilegaard and Neufer 2004). AICAR has been shown
to increase muscle glycogen synthesis (Holmes et al.
1999); however, at least in our experimental design, our
data suggest that increased PDK4 through synergism with
PPARd may be necessary to cause significant glycogen
accumulation which explains the lack of increase in basal
glycogen in A relative to A+G. Increased intramuscular
NEFA at exhaustion in A+G is associated with elevated
mRNA transcription of genes related to fatty acid uptake
in this group as observed with significant elevation in Hsl,
Atgl, Lpl, and Cd36 permitting increased lipolysis from cir-
culating triglycerides as well as uptake of fatty acids in the
muscle. Taken together, the increase in Pdk4 at basal and
during exercise, transcription of fatty acid availability-
related genes, and consequently increased fatty acid avail-
ability during exercise would possibly delay the depletion
of glucose and rapid onset of hypoglycemia consequently
delaying fatigue and cessation of physical activity (Wil-
liams et al. 2013).
The liver not only stores energy in the form of glyco-
gen, but also maintains energy homeostasis by maintain-
ing normal blood glucose concentration through
glycogenolysis and gluconeogenesis as well as ketone body
synthesis during periods of energy deficit (Radziuk and
Pye 2001; Mitra and Metcalf 2009; Cotter et al. 2013).
The nonsignificant increase in total hepatic glycogen in
A+G relative to other exercise-trained groups may be
influenced by the elevated expression of Pgc1a and
Chrebp. Increased hepatic PGC-1a leads to an improve-
ment in oxidative metabolism, gluconeogenesis, and
glycogenesis (Burgess et al. 2006; Finck and Kelly 2006),
while CHREBP downregulation or silencing leads to
decreased glycolysis and lipogenesis resulting in increased
glycogen synthesis (Iizuka and Horikawa 2008). More-
over, elevated hepatic NEFA may suggest increased ketone
body production as well as supply circulating fatty acids
as observed in elevated serum NEFA, both contributing
not only to muscle energy production, but also to sparing
of circulating glucose and glycogen.
Mice in the exercise-trained groups attained hypo-
glycemia at the point of exhaustion with concomitant
exhaustion of liver glycogen not observed in SED. In
SED, however, the absence of hypoglycemia despite reach-
ing exhaustion suggests that other factors other than
hypoglycemia prevented these mice from running longer
(Pi~na et al. 2003), such as complete hepatic glycogen uti-
lization, as well as other factors possibly developed or
enhanced with training. Also, our observations indicate
that muscle glycogen is dispensable in agreement with
Pederson et al. (2005) using MGSKO mouse, a mouse
model lacking muscle glycogen, that it is dispensable for
exercise performance and concluded that muscle glycogen
could limit exercise capacity only if the level of hepatic
glycogen is low coinciding with our observations and
Baldwin et al. (1973).
Exercise induces metabolic changes through the upreg-
ulation of transcription factors. As a major exercise-indu-
cible transcription factor coactivator, PGC-1a has been
shown to improve endurance through mitochondrial bio-
genesis, gluconeogenesis, triglyceride metabolism, glucose
homeostasis, and muscle capillarization (Ryan and
Hoogenraad 2007; Arany et al. 2008; Calvo et al. 2008;
Lira et al. 2010; Narkar et al. 2011). In skeletal muscle,
PPARd together with retinoid X receptor (RXR) activa-
tion controls its transcription while AMPK phosphory-
lates the PGC-1a protein causing its self-induced
upregulation demonstrating the complex direct and indi-
rect interaction of these two proteins (Schuler et al. 2006;
Hondares et al. 2007; J€ager et al. 2007; Narkar et al. 2008;
Gan et al. 2011). Contrary to expectation, Pgc1a was not
elevated in the pre-exercise gastrocnemius at the time of
sampling. However, this is not surprising as reversion to
basal levels toward 24 h postexercise in skeletal muscle
following elevation immediately after exercise has been
reported (Mathai et al. 2008). Because Pgc1a is induced
by exercise, the length of time to exhaustion could influ-
ence the transcription levels in each group, with A+G
running longer, thus having the highest expression level.
This is also reflected by the mRNA expression of some of
its target genes such as PDK4, LPL, and CD36 which are
especially highest in A+G. Oxct1, a key enzyme in ketone
body catabolism that is induced by exercise (Askew et al.
1975), tended to be highest in A+G. Furthermore,
together with increased gene expression not exclusive to
A+G (Hsl, Atgl, Cpt1b, Cs, Vegfa, and Ppard) would sup-
port the observed elevated intramuscular NEFA level at
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the point of exhaustion and the shift to whole-body sub-
strate oxidation to fat toward exhaustion in this group.
Collectively, these findings suggest that combined phar-
macological activation of AMPK and PPARd with exercise
training results in a unique gene signature similar to that
observed in oxidative muscle capable of improved deliv-
ery, uptake, and oxidation of fat and its preferential uti-
lization. On one hand, because pre-exercise test values
likely reverted to baseline as seen in the lack of elevation
in Pgc1a and Lpl and significant but modest elevation in
Pdk4 in A+G, protein expression rather than mRNA
expression may reveal the participation of these genes in
the observed endurance potentiation. On the other hand,
postexercise data presented here may suggest that tran-
scription induction of these genes during running had an
additive or synergistic effect on endurance especially in
A+G.
Exercise training through PGC-1a promotes mitochon-
drial biogenesis consequently influencing oxidative meta-
bolism and energy production (Austin and St-Pierre
2012). The lack of mtDNA increase was not indicative of
increased mitochondrial biogenesis as in muscle, CS activ-
ity is a more reliable marker (Larsen et al. 2012). Indeed,
exercise-trained groups had higher CS activity but inter-
estingly, AICAR-treated groups were significantly
increased. Like PGC-1a mRNA expression, CS activity
presented may already be toward decline beyond 24 h
similar to that observed by Leek et al. (2001). The
observed small but significant elevation in work in A may
be explained by the increase in CS activity. That of A+G,
however, can be attributed to synergism of substrate
availability, utilization shift, and increased mitochondrial
density. Although not measured, metabolism of lactate
and ketone bodies in A and A+G may coincide with
increased mitochondrial density (Baldwin et al. 1978;
Cotter et al. 2013).
Conclusion
While pharmacological activation of AMPK potentiates
endurance in trained and untrained mice as shown here
and many studies (Murase et al. 2005, 2006; Narkar et al.
2008), combined activation with PPARd greatly potenti-
ates endurance through the orchestration of transcrip-
tional programs in the muscle and liver, leading to
increased substrate availability, substrate shift to fat, and
mitochondrial density.
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